Evaluation of Factors Affecting Prescribing Behaviors, in Iran Pharmaceutical Market by Econometric Methods

Overview

Journal Iran J Pharm Res

Publisher Brieflands

Specialty Pharmacology

Date 2015 Apr 23

PMID 25901174

Citations 3

Authors

Nima Tahmasebi

Abbas Kebriaeezadeh

Affiliations

Soon will be listed here.

Abstract

Prescribing behavior of physicians affected by many factors. The present study is aimed at discovering the simultaneous effects of the evaluated factors (including: price, promotion and demographic characteristics of physicians) and quantification of these effects. In order to estimate these effects, Fluvoxamine (an antidepressant drug) was selected and the model was figured out by panel data method in econometrics. We found that insurance and advertisement respectively are the most effective on increasing the frequency of prescribing, whilst negative correlation was observed between price and the frequency of prescribing a drug. Also brand type is more sensitive to negative effect of price than to generic. Furthermore, demand for a prescription drug is related with physician demographics (age and sex). According to the results of this study, pharmaceutical companies should pay more attention to the demographic characteristics of physicians (age and sex) and their advertisement and pricing strategies.

Citing Articles

Pharmaceutical marketing strategies' influence on physicians' prescribing pattern in Lebanon: ethics, gifts, and samples.

Khazzaka M BMC Health Serv Res. 2019; 19(1):80.

PMID: 30700295 PMC: 6354386. DOI: 10.1186/s12913-019-3887-6.

Factors correlating to the propensity of general practitioners to substitute borderline vitamin B12 deficiency.

Cham G, Davis N, Strivens E, Traves A, Manypeney G, Gunnarsson R Scand J Prim Health Care. 2018; 36(3):242-248.

PMID: 29933709 PMC: 6381524. DOI: 10.1080/02813432.2018.1487522.

Generic versus branded medicines: An observational study among patients with chronic diseases attending a public hospital outpatient department.

Das M, Choudhury S, Maity S, Hazra A, Pradhan T, Pal A J Nat Sci Biol Med. 2017; 8(1):26-31.

PMID: 28250671 PMC: 5320819. DOI: 10.4103/0976-9668.198351.

References

Peay M, Peay E . The role of commercial sources in the adoption of a new drug. Soc Sci Med. 1988; 26(12):1183-9. DOI: 10.1016/0277-9536(88)90149-9. View

Andreassen L, Di Tommaso M, Strom S . Do medical doctors respond to economic incentives?. J Health Econ. 2013; 32(2):392-409. DOI: 10.1016/j.jhealeco.2012.12.002. View

Mrazek M . Comparative approaches to pharmaceutical price regulation in the European Union. Croat Med J. 2002; 43(4):453-61. View

Stevenson F, Greenfield S, Jones M, Nayak A, Bradley C . GPs' perceptions of patient influence on prescribing. Fam Pract. 1999; 16(3):255-61. DOI: 10.1093/fampra/16.3.255. View

Wagstaff A, Lindelow M, Jun G, Ling X, Juncheng Q . Extending health insurance to the rural population: an impact evaluation of China's new cooperative medical scheme. J Health Econ. 2008; 28(1):1-19. DOI: 10.1016/j.jhealeco.2008.10.007. View

Chressanthis G, Khedkar P, Jain N, Poddar P, Seiders M . Can access limits on sales representatives to physicians affect clinical prescription decisions? A study of recent events with diabetes and lipid drugs. J Clin Hypertens (Greenwich). 2012; 14(7):435-46. PMC: 8108845. DOI: 10.1111/j.1751-7176.2012.00651.x. View

Schumock G, Walton S, Park H, Nutescu E, Blackburn J, Finley J . Factors that influence prescribing decisions. Ann Pharmacother. 2004; 38(4):557-62. DOI: 10.1345/aph.1D390. View

Ma J, Stafford R, Cockburn I, Finkelstein S . A statistical analysis of the magnitude and composition of drug promotion in the United States in 1998. Clin Ther. 2003; 25(5):1503-17. DOI: 10.1016/s0149-2918(03)80136-4. View

Avorn J, Chen M, Hartley R . Scientific versus commercial sources of influence on the prescribing behavior of physicians. Am J Med. 1982; 73(1):4-8. DOI: 10.1016/0002-9343(82)90911-1. View

10.

Mehralian G, Rajabzadeh Gatari A, Morakabati M, Vatanpour H . Developing a suitable model for supplier selection based on supply chain risks: an empirical study from Iranian pharmaceutical companies. Iran J Pharm Res. 2013; 11(1):209-19. PMC: 3813095. View

11.

Rajabzadeh Ghatari A, Mehralian G, Zarenezhad F, Rasekh H . Developing a model for agile supply: an empirical study from Iranian pharmaceutical supply chain. Iran J Pharm Res. 2013; 12(Suppl):193-205. PMC: 3813359. View

12.

de Frutos M, Ornaghi C, Siotis G . Competition in the pharmaceutical industry: how do quality differences shape advertising strategies?. J Health Econ. 2012; 32(1):268-85. DOI: 10.1016/j.jhealeco.2012.07.006. View

13.

Gemmill M, Thomson S, Mossialos E . What impact do prescription drug charges have on efficiency and equity? Evidence from high-income countries. Int J Equity Health. 2008; 7:12. PMC: 2412871. DOI: 10.1186/1475-9276-7-12. View

14.

Kebriaeezadeh A, Koopaei N, Abdollahiasl A, Nikfar S, Mohamadi N . Trend analysis of the pharmaceutical market in Iran; 1997-2010; policy implications for developing countries. Daru. 2013; 21(1):52. PMC: 3718624. DOI: 10.1186/2008-2231-21-52. View

15.

Adair R, Holmgren L . Do drug samples influence resident prescribing behavior? A randomized trial. Am J Med. 2005; 118(8):881-4. DOI: 10.1016/j.amjmed.2005.02.031. View

16.

Zivin K . How are prescribing decisions made?. Psychiatr Serv. 2013; 64(4):295. DOI: 10.1176/appi.ps.640414. View

17.

Monette J, Tamblyn R, McLeod P, Gayton D, Laprise R . Do medical education and practice characteristics predict inappropriate prescribing of sedative-hypnotics for the elderly?. Acad Med. 1994; 69(10 Suppl):S10-2. DOI: 10.1097/00001888-199410000-00026. View

18.

Berger J . Pharmaceutical industry influences on physician prescribing: gifts, quasi-gifts, and patient-directed gifts. Am J Bioeth. 2003; 3(3):56-7. DOI: 10.1162/15265160360706615. View

19.

Campbell E . Doctors and drug companies--scrutinizing influential relationships. N Engl J Med. 2007; 357(18):1796-7. DOI: 10.1056/NEJMp078141. View

20.

Tamblyn R, McLeod P, Hanley J, Girard N, Hurley J . Physician and practice characteristics associated with the early utilization of new prescription drugs. Med Care. 2003; 41(8):895-908. DOI: 10.1097/00005650-200308000-00004. View